XML 75 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Reporting (Tables)
6 Months Ended
Feb. 28, 2015
Segment Reporting [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The following table reflects results of operations of the Company's reportable segments (in millions):
 
  
Retail Pharmacy
       
  
USA
  
International
  
Pharmaceutical
Wholesale
  
Eliminations
and
Unallocated
Items
  
Consolidated
 
Three Months Ended February 28, 2015
          
Sales to external customers
 
$
21,048
  
$
2,017
  
$
3,508
  
$
-
  
$
26,573
 
Intersegment sales
  
-
   
30
   
357
   
(387
)
  
-
 
Total Sales
  
21,048
   
2,047
   
3,865
   
(387
)
  
26,573
 
Cost of sales
  
15,302
   
1,294
   
3,478
   
(383
)
  
19,691
 
Gross Profit
  
5,746
   
753
   
387
   
(4
)
  
6,882
 
Selling, general and administrative expenses
  
4,555
   
745
   
306
   
-
   
5,606
 
Equity earnings in Alliance Boots
  
101
   
-
   
-
   
-
   
101
 
Operating Income
 
$
1,292
  
$
8
  
$
81
  
$
(4
)
 
$
1,377
 
                     
Three Months Ended February 28, 2014
                    
Sales to external customers
 
$
19,605
  
$
-
  
$
-
  
$
-
  
$
19,605
 
Intersegment sales
  
-
   
-
   
-
   
-
   
-
 
Total Sales
  
19,605
   
-
   
-
   
-
   
19,605
 
Cost of sales
  
13,955
   
-
   
-
   
-
   
13,995
 
Gross Profit
  
5,650
   
-
   
-
   
-
   
5,650
 
Selling, general and administrative expenses
  
4,569
   
-
   
-
   
-
   
4,569
 
Equity earnings in Alliance Boots
  
136
   
-
   
-
   
-
   
136
 
Operating Income
 
$
1,217
  
$
-
  
$
-
  
$
-
  
$
1,217
 
 
  
Retail Pharmacy
       
  
USA
  
International
  
Pharmaceutical Wholesale
  
Eliminations
and
Unallocated
Items
  
Consolidated
 
Six Months Ended February 28, 2015
          
Sales to external customers
 
$
40,602
  
$
2,017
  
$
3,508
  
$
-
  
$
46,127
 
Intersegment sales
  
-
   
30
   
357
   
(387
)
  
-
 
Total Sales
  
40,602
   
2,047
   
3,865
   
(387
)
  
46,127
 
Cost of sales
  
29,560
   
1,294
   
3,478
   
(383
)
  
33,949
 
Gross Profit
  
11,042
   
753
   
387
   
(4
)
  
12,178
 
Selling, general and administrative expenses
  
9,011
   
745
   
306
   
-
   
10,062
 
Equity earnings in Alliance Boots
  
315
   
-
   
-
   
-
   
315
 
Operating Income
 
$
2,346
  
$
8
  
$
81
  
$
(4
)
 
$
2,431
 
                     
Six Months Ended February 28, 2014
                    
Sales to external customers
 
$
37,934
  
$
-
  
$
-
  
$
-
  
$
37,934
 
Intersegment sales
  
-
   
-
   
-
   
-
   
-
 
Total Sales
  
37,934
   
-
   
-
   
-
   
37,934
 
Cost of sales
  
27,132
   
-
   
-
   
-
   
27,132
 
Gross Profit
  
10,802
   
-
   
-
   
-
   
10,802
 
Selling, general and administrative expenses
  
8,948
   
-
   
-
   
-
   
8,948
 
Equity earnings in Alliance Boots
  
330
   
-
   
-
   
-
   
330
 
Operating Income
 
$
2,184
  
$
-
  
$
-
  
$
-
  
$
2,184
 
                     
Total assets:
                    
February 28, 2015
 
$
77,466
  
$
22,131
  
$
13,706
  
$
(41,946
)
 
$
71,357
 
August 31, 2014
  
44,275
   
-
   
-
   
(7,005
)
  
37,270
 
Schedule of Earnings Before Interest and Income Tax Provision
The following table reconciles the operating income from each reportable segment to earnings before interest and income tax provision (in millions):

  
For the Three Months Ended
  
For the Six Months Ended
 
  
February 28,
2015
  
February 28,
2014
  
February 28,
2015
  
February 28,
2014
 
Operating income:
        
Retail Pharmacy USA
 
$
1,292
  
$
1,217
  
$
2,346
  
$
2,184
 
Retail Pharmacy International
  
8
   
-
   
8
   
-
 
Pharmaceutical Wholesale
  
81
   
-
   
81
   
-
 
Eliminations/Other
  
(4
)
  
-
   
(4
)
  
-
 
Gain on previously held equity interest
  
706
   
-
   
706
   
-
 
Other (expense) income
  
504
   
(59
)
  
703
   
166
 
Earnings Before Interest and Tax provision (EBIT)
 
$
2,587
  
$
1,158
  
$
3,840
  
$
2,350